Allarity Therapeutics, Inc.: Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement

Allarity Therapeutics, Inc. (ALLR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign - Completed quarter with $26.9 million in cash and restricted cash - Key U.S. patent was awarded, protecting exclusivity of stenoparib when

Allarity Therapeutics (NASDAQ: ALLR) reported Q2 2026 results and said it ended June 30 with $26.9 million in cash and restricted cash. The company said the USPTO granted a key patent for its stenoparib-specific DRP companion diagnostic through April 2042, and it completed its stenoparib Phase 3-ready manufacturing campaign and obtained CLIA certification for in-house DRP testing.

Allarity Therapeutics (NASDAQ: ALLR) said it obtained CLIA Certificate of Registration for its in-house laboratory in Horsholm, Denmark, enabling it to run DRP® biomarker testing internally for FDA registration-related studies. The company expects faster turnaround, streamlined trial communication, and lower long-term costs, and may offer CLIA-compliant testing services to partners.

Microsoft plans to expand its data center capacity from 12 GW to 38 GW by 2032, aiming to address capacity shortages that have led to lost clients and service restrictions. The expansion, the largest in the company's history, faces political and physical constraints, including grid interconnection delays and community opposition. Microsoft's capital expenditures reached $145 billion in fiscal year 2026, with additional lease commitments totaling $329 billion. The company has also extended the es

CF Industries, JERA, and Mitsui launched a $3.7B low-carbon ammonia plant in Louisiana, with a 1.4M metric ton capacity. Operational by 2029, it will use ATR technology and capture 98% of CO2. CF Industries leads with 40% investment, while Linde and a 1PointFive-Enbridge JV also contribute. The plant aims to support agricultural and energy needs, creating jobs and boosting U.S. export capacity.

Netflix raised UK subscription prices: basic plan with ads to £7.99/month, standard ad-free to £13.99/month, and premium to £20.99/month. Existing customers will receive a one-month notice. Netflix cited increased entertainment choices and commitment to quality. Other streaming services like Disney+ and Amazon Video have also raised prices. Analysts suggest reviewing subscriptions to cut costs, such as downgrading or canceling unused services.